A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
Clinical trial NCT06548854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06548854
- Sponsor
- Grand Medical Pty Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2024-11-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.